Tel: +44 (0)20 7377 0800
Fax: +44 (0)20 7349 5157
Tel: +81 (0)80-1164-4754
Request a Demo
What our customers are saying
When I think of the future, I think of EvaluatePharma
Global pharmaceutical company
Jonathan de Pass, Founder and Chairman
|Dr. de Pass, a world-recognized leader in market intelligence and analysis for the life science sector, has led the way in creating new industry standards for forecasting global drug sales and other performance metrics. Prior to founding EvaluatePharma in 1996, Dr. de Pass was a top-ranked pharmaceutical analyst in the London investment-banking arena, where his insights guided venture capital and securities investments. He earned a Masters in Management from the London Business School, and Bachelor of Medicine and Bachelor of Surgery degrees from the University of Bristol in the U.K.
Alex Karle, CEO
||Mr. Karle joined Evaluate in 2012 as Chief Operating Officer and took on the role of Chief Executive Officer in 2014. Prior to Evaluate, Mr. Karle spent 10 years at Thomson Reuters in various executive roles including Vice President, Business Development & Strategy - IP & Science and General Manager of CMR, a Thomson Reuters business. Mr. Karle began his career as a Senior Associate with Booz Allen & Hamilton’s Media and Communications practice in New York. He holds an MBA from Yale University and a BA (Hons) in Business, Economics and Law from the European Business Programme, Münster, Germany and Hull, United Kingdom.|
Debbie Paul, CEO, EvaluatePharma USA, Inc.
|Ms. Paul brings more than 20 years of diverse healthcare industry experience to her role leading EvaluatePharma USA Inc. both as Senior Vice President, North America and in her current role. Ms. Paul previously served as director of market research at Sandoz, the generics division of global pharmaceuticals company Novartis AG, where she led strategic and product planning. She also worked at in the pharmaceutical and medical products practice of management consultancy McKinsey & Co. Inc. Paul received her Masters of Business Administration from Rice University in Houston, Texas, following a 17-year career as a Critical Care Nurse. Ms. Paul also holds a Bachelor of Science in Nursing from State University of New York in Albany.
Gerard Sebastian, Chief Finance Officer
||Mr. Sebastian heads up the Finance function at EvaluatePharma. With some thirty years’ experience, prior to joining EvaluatePharma, he has worked for a decade in large international corporations in manufacturing and in communication. His last decade was spent principally working in eCommerce within the online arena, with particular emphasis in helping small and medium sized internet-based companies to develop from start-up stage to trading online successfully. |
Will Hau, Senior Vice President, Sales & Account Management
|Mr Hau brings nearly 30 years’ of commercial experience in the business information sector to his role as Senior Vice President, Sales & Account Management, with responsibility for Evaluate’s Sales operations outside of the Americas. Prior to joining Evaluate, Mr Hau was Global Marketing Director and then Sales Director for Datamonitor’s Healthcare business unit, Global Marketing Director and Sales Director for Adis International’s Knowledge Bases group, and Global Marketing Director for IMS Healthcare. A zoology graduate from Manchester University, and holding a Professional Diploma in Marketing from the Chartered Institute of Marketing, Mr Hau has also worked in medical sales, for Squibb and 3M Healthcare.
Anthony Raeside, Head of Research
||Mr. Raeside leads Evaluate's analyst teams, currently numbering over 95 staff globally, providing life science sector analysis and commercial insight into the biotechnology, pharmaceutical and medical device industries. He joined EvaluatePharma in 1997 and has been responsible for content development and strategy, to continually enhance the value of Evaluate services to its client base. He is an economics graduate of the London School of Economics and Political Science.|